NIH Health Information Page NIH Impact NIH Fact Sheets NIA SeniorHealth.gov NIH Podcast
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Press Releases

 

NIH-Funded News

 
  For News & Research
  NIH Radio
  NIH Podcasts
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services


News from the National Institutes of Health

NIH-Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 3306.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 23-Jul-2013
HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
Even in the absence of a ready solution, knowing why a child faces physical, emotional and intellectual challenges is helpful to physicians and families. Researchers at the HudsonAlpha Institute for Biotechnology are using high throughput genomic sequencing to meet major diagnostic needs for childhood genetic disorders through a multi-year grant potentially totaling more than $7.6 million from the National Institutes of Health. The study grant is part of the NIH's Clinical Sequencing Exploratory Research program.
NIH/National Human Genome Research Institute Clinical Sequencing Exploratory Research

Contact: Holly Ralston
hralston@hudsonalpha.org
256-508-8954
HudsonAlpha Institute for Biotechnology

Public Release: 23-Jul-2013
SIGGRAPH 2013
ACM Transactions on Graphics
Perfecting digital imaging
Three Harvard papers presented at SIGGRAPH this week aim to improve computer graphics and display technologies! One tackles the challenge of rendering realistic translucent objects like soap; the second creates a new type of 3D display technology; and the third makes color grading accessible to amateur videographers.
National Science Foundation, National Institutes of Health, European Research Council, and others

Contact: Caroline Perry
cperry@seas.harvard.edu
617-496-1351
Harvard University

Public Release: 23-Jul-2013
Epidemiology
Study: No link between mercury exposure and autism-like behaviors
The potential impact of exposure to low levels of mercury on the developing brain -- specifically by women consuming fish during pregnancy -- has long been the source of concern and some have argued that the chemical may be responsible for behavioral disorders such as autism. However, a new study that draws upon more than 30 years of research in the Republic of Seychelles reports that there is no association between pre-natal mercury exposure and autism-like behaviors.
NIH/National Institute of Environmental Health Sciences, Government of the Republic of Seychelles

Contact: Mark Michaud
mark_michaud@urmc.rochester.edu
585-273-4790
University of Rochester Medical Center

Public Release: 23-Jul-2013
Nature
Controlling genes with light
A new technology developed at MIT and the Broad Institute can rapidly start or halt the expression of any gene of interest simply by shining light on the cells.
Hubert Schoemaker Felllowship, NIH/Transformative R01 & Director's Pioneer Award, and others

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 23-Jul-2013
Nature Communications
A new weapon against stroke
Stem cell research for stroke has focused on developing therapeutic neurons -- the primary movers of electrical impulses in the brain -- to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
National Institutes of Health, National Multiple Sclerosis Society, California Institute for Regenerative Medicine, Shriners Hospitals for Children

Contact: Charles Casey
charles.casey@ucdmc.ucdavis.edu
916-734-9048
University of California - Davis Health System

Public Release: 23-Jul-2013
Molecular Therapy - Nucleic Acids
Digital PCR technology detects brain-tumor-associated mutation in cerebrospinal fluid
Massachusetts General Hospital researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid of patients with brain tumors.
National Institutes of Health, Brain Tumor Funders' Collaborative, American Brain Tumor Assocoation

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 23-Jul-2013
University of Tennessee professors explore end-of-life needs for HIV/AIDS patients
Approximately 10,000 Americans die with an HIV/AIDS diagnosis each year, and many of these patients lack access to the care they need at the end of their lives. This is especially true for those who live in the Appalachian region. A group of nursing professors at the University of Tennessee, Knoxville, is embarking on a study to try to change this.
National Institutes of Health

Contact: Whitney Heins
wheins@utk.edu
865-974-5460
University of Tennessee at Knoxville

Public Release: 22-Jul-2013
Nature
Evolution picks up hitchhikers
In a twist on "survival of the fittest," researchers have discovered that evolution is driven not by a single beneficial mutation but rather by a group of mutations, including ones called "genetic hitchhikers" that are simply along for the ride. These hitchhikers are mutations that do not appear to have a role in contributing to an organism's fitness and therefore its evolution, yet may play an important role down the road.
NIH/National Institute of General Medical Sciences Centers of Excellence

Contact: Morgan Kelly
mgnkelly@princeton.edu
609-258-5729
Princeton University

Public Release: 22-Jul-2013
JAMA Internal Medicine
Former prisoners more likely to be hospitalized for preventable conditions
Complications of diabetes, hypertension, asthma, and other preventable conditions are more likely to land former prisoners in the hospital, Yale School of Medicine researchers report in the July 22 online issue of JAMA Internal Medicine.
NIH/National Heart, Lung, and Blood Institute, NIH/National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center Award

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University

Public Release: 22-Jul-2013
Scientists to study novel mechanisms of epileptic seizures to identify targets for therapy
UC Riverside's Todd Fiacco and Devin Binder will study the causes of neuronal hyperexcitability with the goal of developing more effective treatments for brain disorders. They share a five-year National Institutes of Health grant totaling more than $1.7 million awarded to them. Besides improving our understanding of how brain cells communicate with each other, the research has the potential to lead to treatments for brain disorders and diseases such as epilepsy, stroke and Alzheimer's disease.
National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 22-Jul-2013
Prevention Science
Teen eating disorders increase suicide risk
Is binge eating a tell-tale sign of suicidal thoughts? According to a new study of African American girls published in Springer's journal Prevention Science, those who experience depressive and anxious symptoms are often dissatisfied with their bodies and more likely to display binge eating behaviors. These behaviors put them at higher risk for turning their emotions inward, in other words, displaying internalizing symptoms such as suicide.
NIH/National Institute of Mental Health, NIH/National Institute on Drug Abuse, Maternal and Child Health Bureau

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 22-Jul-2013
Nature Neuroscience
The love hormone is 2-faced
Oxytocin is known as the hormone that promotes feelings of love, bonding and well-being. It's even being tested as an anti-anxiety drug. But new research shows oxytocin also can cause emotional pain. Oxytocin appears to be the reason stressful social situations, perhaps being bullied at school or tormented by a boss, reverberate long past the event and can trigger fear and anxiety in the future. That's because the hormone actually strengthens social memory in the brain.
NIH/National Institute of Mental Health

Contact: Marla Paul
Marla-Paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 22-Jul-2013
Journal of Clinical Investigation
Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
Researchers at Moffitt Cancer Center and Tianjin Medical University Cancer Institute and Hospital in China have discovered a gene expression signature that may lead to new immune therapies for lung cancer patients. They found that NF-κB, a protein complex known to promote tumor growth, may also have the ability to boost the immune system to eliminate cancerous cells before they harm, as well as promote antitumor responses.
NIH/National Cancer Institute

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute

Public Release: 22-Jul-2013
Green Chemistry
Carnegie Mellon-developed chemicals that break down water contaminants pass safety test
A family of molecules developed at Carnegie Mellon University to break down pollutants in water is one step closer to commercial use. Study results published online in the journal Green Chemistry show that the molecules, which are aimed at removing hazardous endocrine disruptors from water sources, aren't endocrine disruptors themselves as they proved to be non-toxic to developing zebrafish embryos.
Heinz Endowments, R.K. Mellon Foundation, NIH/National Institute of Environmental Health Sciences

Contact: Jocelyn Duffy
jhduffy@andrew.cmu.edu
412-268-9982
Carnegie Mellon University

Public Release: 22-Jul-2013
mBio
Study lays groundwork for norovirus anti-viral treatments
There's no vaccine to prevent norovirus, or drugs to treat the pesky virus that sickens millions each year and is known to complicate cruise ship vacations. But a first ever small animal model created at the University of Michigan Medical School provides a new tool to develop anti-viral treatments.
National Institutes of Health

Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 22-Jul-2013
Circulation: Journal of the American Heart Association
Skipping breakfast may increase coronary heart disease risk
A large 16-year study finds men who reported that they skipped breakfast had higher risk of heart attack or death from coronary heart disease. The timing of meals, whether it's missing a meal in the morning or eating a meal very late at night, may cause adverse metabolic effects that lead to coronary heart disease.
National Institutes of Health, Canadian Institutes of Health Research Postdoctoral Research

Contact: Karen Astle
karen.astle@heart.org
214-706-1392
American Heart Association

Public Release: 21-Jul-2013
Nature Chemical Biology
Failure to destroy toxic protein -- not buildup of protein itself -- contributes to Huntington's disease
Neurodegenerative diseases are often associated with the buildup of toxic proteins that lead to the death of neurons. But now, scientists at the Gladstone Institutes have discovered that the progression of disease is not due to the buildup of toxins itself, but rather in the individual neurons' ability to flush these toxins out. Further, they have identified a therapeutic target that could boost this ability, thereby protecting the brain from the diseases' deadly effects.
NIH/National Institute of Neurological Disorders and Stroke, NIH/National Institute on Aging, NIH/National Center for Research Resources, Huntington's Disease Society of America, Taube-Koret, HDF, Hilbolm Foundation, CIRM

Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes

Public Release: 21-Jul-2013
Nature
Common stem cell in heart and lung development explains adaption for life on land
Biologists have known that the co-development of the cardiovascular and pulmonary systems is a recent evolutionary adaption to life outside of water. Researchers show that the pulmonary vasculature develops even in the absence of the lung. Mice in which lung development is inhibited still have pulmonary blood vessels, which revealed to the researchers that cardiac progenitors, or stem cells, are essential for cardiopulmonary co-development.
NIH/National Heart, Lung and Blood Institute, American Heart Assocation

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 21-Jul-2013
Nature Medicine
A bad alliance: Rare immune cells promote food-induced allergic inflammation in the esophagus
Until recently, how EoE, a food allergy-associated disease, developed was unclear, but a new study shows that a type of rare immune cell and specific reactions to allergenic foods team up -- in a bad way. This association does point to new ways to possibly treat inflammation associated with EoE.
NIH/National Institute Allergy and Infectious Disease, NIH/National Institute of Diabetes and Digestive and Kidney Disorders

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 21-Jul-2013
Nature Genetics
Sex chromosome shocker: The 'female' X a key contributor to sperm production
Painstaking new analysis of the genetic sequence of the X chromosome—long perceived as the "female" counterpart to the male-associated Y chromosome—reveals that large portions of the X have evolved to play a specialized role in sperm production.
National Institutes of Health

Contact: Matt Fearer
fearer@wi.mit.edu
617-452-4630
Whitehead Institute for Biomedical Research

Public Release: 19-Jul-2013
Nature Cell Biology
Stem cell discovery furthers research on cell-based therapy and cancer
Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
National Institutes of Health, California Institute for Regenerative Medicine

Contact: Jeffrey Norris
jeff.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 19-Jul-2013
PLOS Genetics
Gene mutation in dogs offers clues for neural tube defects in humans
A gene related to neural tube defects in dogs has for the first time been identified by researchers at the University of California, Davis, and University of Iowa. The gene may be an important risk factor for human neural tube defects, including anencephaly and spina bifida.
UC Davis Center for Companion Animal Health, NIH/National Institute of Allergy and Infectious Diseases, Weimaraner Club of America

Contact: Pat Bailey
pjbailey@ucdavis.edu
530-752-9843
University of California - Davis

Public Release: 19-Jul-2013
Immunity
U of M researchers identify new functions for autoimmune disease 'risk' gene
Researchers at the University of Minnesota have identified infection-fighting and inflammation-suppressing functions for a gene associated with human autoimmune disease. The discovery, centered on a gene known as PTPN22, could set into motion new treatment approaches for autoimmune diseases like lupus, rheumatoid arthritis and type 1 diabetes.
National Institutes of Health, American College of Rheumatology, American Diabetes Association, Alliance for Lupus Research

Contact: Caroline Marin
crmarin@umn.edu
612-624-5680
University of Minnesota Academic Health Center

Public Release: 19-Jul-2013
Journal of American Geriatrics Society
Regenstrief, IU study: Caregivers open to stopping cancer screening as dementia progresses
Research from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many family caregivers of older adults with dementia are willing to consider stopping cancer screening of the elderly individual; they are also relieved when the older adult's physician brings it up.
NIH/National Institute on Aging

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University

Public Release: 18-Jul-2013
Proceedings of the National Academy of Sciences
Deadliest cancers may respond to new drug treatment strategy
UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments. 
National Institutes of Health, Waxman Foundation, Howard Hughes Medical Institute, Truitt

Contact: Jeffrey Norris
jeff.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Showing releases 101-125 out of 3306.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2013 by AAAS, the science society.